{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:45:22Z","timestamp":1794584722610,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-957","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T06:43:03Z","timestamp":1434609783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["MICA\/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Hanbyoul","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Heung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Joo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"issue":"2","key":"5142_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","volume":"20","author":"R Sankaranarayanan","year":"2006","unstructured":"Sankaranarayanan R, Ferlay J: Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006, 20 (2): 207-225. 10.1016\/j.bpobgyn.2005.10.007.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"5142_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003, 88 (1): 63-73. 10.1038\/sj.bjc.6600688.","journal-title":"Br J Cancer"},{"issue":"3","key":"5142_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.11222","volume":"106","author":"V Dalstein","year":"2003","unstructured":"Dalstein V, Riethmuller D, Pretet JL, Le Bail CK, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C: Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003, 106 (3): 396-403. 10.1002\/ijc.11222.","journal-title":"Int J Cancer"},{"issue":"2","key":"5142_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"PJ Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ: HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006, 208 (2): 152-164. 10.1002\/path.1866.","journal-title":"J Pathol"},{"issue":"1","key":"5142_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3802\/jgo.2013.24.1.59","volume":"24","author":"WC Lee","year":"2013","unstructured":"Lee WC, Lee SY, Koo YJ, Kim TJ, Hur SY, Hong SR, Kim SS, Kee MK, Rhee JE, Lee JS, Choi HS, Cho CH, Kim KT, Park JS: Establishment of a Korea HPV cohort study. J Gynecol Oncol. 2013, 24 (1): 59-65. 10.3802\/jgo.2013.24.1.59.","journal-title":"J Gynecol Oncol"},{"issue":"12","key":"5142_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/oxfordjournals.aje.a010165","volume":"151","author":"L Ahdieh","year":"2000","unstructured":"Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, Shah K: Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol. 2000, 151 (12): 1148-1157. 10.1093\/oxfordjournals.aje.a010165.","journal-title":"Am J Epidemiol"},{"key":"5142_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","volume":"47","author":"G Trinchieri","year":"1989","unstructured":"Trinchieri G: Biology of natural killer cells. Adv Immunol. 1989, 47: 187-376.","journal-title":"Adv Immunol"},{"issue":"3","key":"5142_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","volume":"88","author":"S Ishigami","year":"2000","unstructured":"Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, Iwashige H, Aridome K, Hokita S, Aikou T: Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 2000, 88 (3): 577-583. 10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V.","journal-title":"Cancer"},{"issue":"1","key":"5142_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0169-5002(01)00292-6","volume":"35","author":"FR Villegas","year":"2002","unstructured":"Villegas FR, Coca S, Villarrubia VG, Jimenez R, Chillon MJ, Jareno J, Zuil M, Callol L: Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer. 2002, 35 (1): 23-28. 10.1016\/S0169-5002(01)00292-6.","journal-title":"Lung Cancer"},{"issue":"2","key":"5142_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000292322","volume":"40","author":"GG Garzetti","year":"1995","unstructured":"Garzetti GG, Ciavattini A, Muzzioli M, Goteri G, Mannello B, Romanini C, Fabris N: Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up. Gynecol Obstet Invest. 1995, 40 (2): 133-138. 10.1159\/000292322.","journal-title":"Gynecol Obstet Invest"},{"issue":"10","key":"5142_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet DH: Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003, 3 (10): 781-790. 10.1038\/nri1199.","journal-title":"Nat Rev Immunol"},{"issue":"22","key":"5142_CR12","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1073\/pnas.93.22.12445","volume":"93","author":"V Groh","year":"1996","unstructured":"Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T: Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996, 93 (22): 12445-12450. 10.1073\/pnas.93.22.12445.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5142_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ijc.10966","volume":"104","author":"M Jinushi","year":"2003","unstructured":"Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, Kimura R, Miyagi T, Mochizuki K, Sasaki Y, Hayashi N: Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer. 2003, 104 (3): 354-361. 10.1002\/ijc.10966.","journal-title":"Int J Cancer"},{"issue":"10","key":"5142_CR14","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/ijc.23733","volume":"123","author":"S Textor","year":"2008","unstructured":"Textor S, Durst M, Jansen L, Accardi R, Tommasino M, Trunk MJ, Porgador A, Watzl C, Gissmann L, Cerwenka A: Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer. 2008, 123 (10): 2343-2353. 10.1002\/ijc.23733.","journal-title":"Int J Cancer"},{"issue":"7","key":"5142_CR15","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.0730640100","volume":"100","author":"R Castriconi","year":"2003","unstructured":"Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A: Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A. 2003, 100 (7): 4120-4125. 10.1073\/pnas.0730640100.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"5142_CR16","first-page":"6178","volume":"62","author":"D Pende","year":"2002","unstructured":"Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A: Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002, 62 (21): 6178-6186.","journal-title":"Cancer Res"},{"issue":"3","key":"5142_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000, 92 (3): 205-216. 10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"5142_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD: Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002, 3 (11): 991-998. 10.1038\/ni1102-991.","journal-title":"Nat Immunol"},{"issue":"22","key":"5142_CR19","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1158\/1078-0432.CCR-09-0991","volume":"15","author":"RW McGilvray","year":"2009","unstructured":"McGilvray RW, Eagle RA, Watson NF, Al-Attar A, Ball G, Jafferji I, Trowsdale J, Durrant LG: NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting. Clin Cancer Res. 2009, 15 (22): 6993-7002. 10.1158\/1078-0432.CCR-09-0991.","journal-title":"Clin Cancer Res"},{"key":"5142_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD: The three Es of cancer immunoediting. Annu Rev Immunol. 2004, 22: 329-360. 10.1146\/annurev.immunol.22.012703.104803.","journal-title":"Annu Rev Immunol"},{"issue":"6832","key":"5142_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","volume":"410","author":"V Shankaran","year":"2001","unstructured":"Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001, 410 (6832): 1107-1111. 10.1038\/35074122.","journal-title":"Nature"},{"issue":"20","key":"5142_CR22","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1073\/pnas.201238598","volume":"98","author":"A Cerwenka","year":"2001","unstructured":"Cerwenka A, Baron JL, Lanier LL: Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001, 98 (20): 11521-11526. 10.1073\/pnas.201238598.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6852","key":"5142_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/35093109","volume":"413","author":"A Diefenbach","year":"2001","unstructured":"Diefenbach A, Jensen ER, Jamieson AM, Raulet DH: Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001, 413 (6852): 165-171. 10.1038\/35093109.","journal-title":"Nature"},{"issue":"5","key":"5142_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1084\/jem.20050994","volume":"202","author":"MJ Smyth","year":"2005","unstructured":"Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y: NKG2D function protects the host from tumor initiation. J Exp Med. 2005, 202 (5): 583-588. 10.1084\/jem.20050994.","journal-title":"J Exp Med"},{"issue":"9","key":"5142_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ni.1642","volume":"9","author":"N Stern-Ginossar","year":"2008","unstructured":"Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, Mandelboim M, Mandelboim O: Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol. 2008, 9 (9): 1065-1073. 10.1038\/ni.1642.","journal-title":"Nat Immunol"},{"issue":"7054","key":"5142_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nature03884","volume":"436","author":"S Gasser","year":"2005","unstructured":"Gasser S, Orsulic S, Brown EJ, Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005, 436 (7054): 1186-1190. 10.1038\/nature03884.","journal-title":"Nature"},{"issue":"14","key":"5142_CR27","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","volume":"65","author":"S Armeanu","year":"2005","unstructured":"Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR: Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 2005, 65 (14): 6321-6329. 10.1158\/0008-5472.CAN-04-4252.","journal-title":"Cancer Res"},{"issue":"8","key":"5142_CR28","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.4049\/jimmunol.176.8.5108","volume":"176","author":"N Boissel","year":"2006","unstructured":"Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, Rousselot P, Tamouza R, Le Bouteiller P, Mahon FX, Steinle A, Salih HR: BCR\/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J Immunol. 2006, 176 (8): 5108-5116. 10.4049\/jimmunol.176.8.5108.","journal-title":"J Immunol"},{"issue":"5","key":"5142_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00262-008-0585-3","volume":"58","author":"K Li","year":"2009","unstructured":"Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I: Clinical significance of the NKG2D ligands, MICA\/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol Immunother. 2009, 58 (5): 641-652. 10.1007\/s00262-008-0585-3.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"5142_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/157339509787314369","volume":"5","author":"RA Eagle","year":"2009","unstructured":"Eagle RA, Jafferji I, Barrow AD: Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr Immunol Rev. 2009, 5 (1): 22-34. 10.2174\/157339509787314369.","journal-title":"Curr Immunol Rev"},{"issue":"3","key":"5142_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.humimm.2006.02.015","volume":"67","author":"RA Eagle","year":"2006","unstructured":"Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J: Regulation of NKG2D ligand gene expression. Hum Immunol. 2006, 67 (3): 159-169. 10.1016\/j.humimm.2006.02.015.","journal-title":"Hum Immunol"},{"issue":"9","key":"5142_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nri2144","volume":"7","author":"RA Eagle","year":"2007","unstructured":"Eagle RA, Trowsdale J: Promiscuity and the single receptor: NKG2D. Nat Rev Immunol. 2007, 7 (9): 737-744. 10.1038\/nri2144.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"5142_CR33","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/ijc.25156","volume":"127","author":"RW McGilvray","year":"2010","unstructured":"McGilvray RW, Eagle RA, Rolland P, Jafferji I, Trowsdale J, Durrant LG: ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients. Int J Cancer. 2010, 127 (6): 1412-1420. 10.1002\/ijc.25156.","journal-title":"Int J Cancer"},{"issue":"26","key":"5142_CR34","doi-asserted-by":"publisher","first-page":"18922","DOI":"10.1074\/jbc.M702504200","volume":"282","author":"W Cao","year":"2007","unstructured":"Cao W, Xi X, Hao Z, Li W, Kong Y, Cui L, Ma C, Ba D, He W: RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. J Biol Chem. 2007, 282 (26): 18922-18928. 10.1074\/jbc.M702504200.","journal-title":"J Biol Chem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-957\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:44:41Z","timestamp":1630568681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5142"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-957","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"27 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"957"}}